Actively Recruiting
A Cohort Establishment Study of Total Management of Ovarian Cancer
Led by Sichuan Cancer Hospital and Research Institute · Updated on 2024-06-20
500
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A cohort establishment study of total management of ovarian cancer (including fallopian tube cancer and primary peritoneal cancer).
CONDITIONS
Official Title
A Cohort Establishment Study of Total Management of Ovarian Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with ovarian cancer (including fallopian tube cancer, primary peritoneal cancer) and intended to be treated in our hospital
- Can cooperate with later follow-up
You will not qualify if you...
- Patients with other malignant tumors or previous history of other malignant tumors
- Have cognitive impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sichuan Cancer Hospital
Chengdu, China
Actively Recruiting
Research Team
D
Dengfeng Wang, Learned scholar
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here